公式財務諸表に基づく売上高、利益、キャッシュフローの推移。
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→
| 損益計算書 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 売上高合計 | $17.0B | $16.3B | $15.4B | $15.0B | $14.4B | $13.9B | $11.4B | $11.1B | $10.4B | $9.7B | $6.8B | $5.7B | $5.5B | $5.1B | $4.9B | $4.3B | $3.9B |
| 売上総利益 | $4.5B | $4.3B | $5.4B | $5.2B | $5.0B | $4.6B | $3.9B | $3.8B | $3.7B | $3.4B | $2.1B | $1.6B | $1.5B | $1.3B | $1.2B | $1.1B | $1.1B |
| 売上総利益率 % | 26.2% | 26.3% | 34.9% | 35.0% | 34.9% | 33.5% | 34.0% | 34.2% | 35.2% | 35.0% | 30.3% | 28.3% | 27.5% | 26.2% | 25.3% | 26.4% | 28.5% |
| 営業利益（EBIT） | $2.4B | $2.3B | $2.2B | $2.0B | $1.8B | $1.4B | $731M | $777M | $741M | $719M | $642M | $647M | $590M | $462M | $396M | $345M | $395M |
| 営業利益率 % | 13.9% | 14.0% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 7.4% | 9.4% | 11.3% | 10.8% | 9.1% | 8.2% | 8.0% | 10.1% |
| 当期純利益 | $1.4B | $1.4B | $1.4B | $1.4B | $1.1B | $966M | $279M | $191M | $259M | $1.3B | $115M | $387M | $356M | $227M | $178M | $242M | $161M |
| 純利益率 % | 8.1% | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.5% | 1.7% | 6.8% | 6.5% | 4.4% | 3.6% | 5.6% | 4.1% |
| EBITDA | — | $3.5B | $3.5B | $3.3B | $2.9B | $2.8B | $2.1B | $2.0B | $1.9B | $1.7B | $849M | $768M | $723M | $554M | $500M | $386M | $467M |
| 1株当たり利益（EPS） | $8.06 | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $1.43 | $0.96 | $1.24 | $5.88 | $0.76 | $3.08 | $2.72 | $1.77 | $1.39 | $1.90 | $1.26 |
| 発行済株式数（百万株） | — | 174M | 183M | 186M | 191M | 195M | 195M | 200M | 208M | 223M | 152M | 126M | 131M | 128M | 128M | 128M | 128M |
出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。
貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は IQV のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/IQV
本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。
About TickerBase · Data methodology & sources · Privacy · Terms